Xtalks Life Science Webinars
Treiber and Rosen will address current best practices that enhance vaccine trials performance, such as including experienced sites in protocol development and how to focus site selection to maximize patient numbers across fewer sites for reduced variability.
TORONTO (PRWEB)
June 11, 2020
Will COVID-19 spur disruptive innovation in vaccine studies? The current pandemic has put a bright spotlight on vaccine trials, showing why it’s never been more urgent for robust and thoughtful vaccine trial designs that can be executed efficiently and nimbly. Typically shorter in duration relative to other trials, vaccine trials can cause an increased pressure to plan and execute adeptly.
Treiber and Rosen will address current best practices that enhance vaccine trials performance, such as including experienced sites in protocol development and how to focus site selection to maximize patient numbers across fewer sites for reduced variability. They will detail operational guidance like abbreviate ICFs for rapid pre-screening, pre-emptive measures to accelerate enrollment and operational efficiencies that can improve the speed and quality of vaccine trials. Historical case studies (Zika, Dengue, Chikungunya) will be discussed to demonstrate how these changed the approach to subsequent trials.
Each trial presents its own specific challenges. How will the current pandemic inform, adapt, or completely alter some of these proven strategies? Current events put into sharper focus the need for streamlined, accessible technologies that can make vaccine trials quicker, easier and more patient-centric.
Can tools such as ePRO diaries, telemedicine, HIPAA-compliant virtual systems and more aid in delivering results faster while maintaining quality? The presenters will explore these topics and provide practical insights on how vaccine trial planning and execution can evolve moving forward.
Join Scott Treiber, PhD, MBA, Vice President, Strategic Development, Synteract and Jeffrey Rosen, MD, Chief Medical Officer, Alliance of MultiSpecialty Research (AMR) in a live webinar on Tuesday, June 30, 2020 at 11am EDT (4pm BST/UK).
For more information or to register for this event, visit Addressing the Rapidly Evolving Vaccine Development Landscape.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Share article on social media or email: